Advisor Group’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$78K Sell
2,126
-231
-10% -$8.19K ﹤0.01% 3115
2019
Q3
$79K Sell
2,357
-195
-8% -$6.91K ﹤0.01% 3067
2019
Q2
$100K Sell
2,552
-2
-0.1% -$79 ﹤0.01% 2862
2019
Q1
$103K Sell
2,554
-5,472
-68% -$204K ﹤0.01% 2830
2018
Q4
$260K Sell
8,026
-160
-2% -$6.46K ﹤0.01% 1898
2018
Q3
$421K Buy
8,186
+1,602
+24% +$80.2K ﹤0.01% 1591
2018
Q2
$331K Buy
6,584
+487
+8% +$24.7K ﹤0.01% 1621
2018
Q1
$311K Buy
6,097
+269
+5% +$14.3K ﹤0.01% 1666
2017
Q4
$307K Sell
5,828
-3,355
-37% -$167K ﹤0.01% 1678
2017
Q3
$449K Buy
9,183
+1,015
+12% +$48.3K 0.01% 1274
2017
Q2
$394K Buy
8,168
+312
+4% +$14.4K 0.01% 1301
2017
Q1
$331K Sell
7,856
-899
-10% -$37.2K 0.01% 1318
2016
Q4
$370K Sell
8,755
-15
-0.2% -$612 0.01% 1176
2016
Q3
$384K Buy
8,770
+672
+8% +$30.1K 0.01% 1121
2016
Q2
$350K Buy
+8,098
New +$349K 0.01% 1108

Other funds holding FMS

Advisor Group's FMS Position: Q4 2019 in Review

Advisor Group reduced its Fresenius Medical Care (FMS) stake by 9.8% in Q4 2019, selling an estimated $8.19K and leaving 2,126 shares worth $78K. The position accounts for ﹤0.01% of the portfolio, ranked #3115.

Advisor Group first reported a position in FMS in Q2 2016 and has held it in 15 quarters since. The position peaked at $449K in Q3 2017. 171 funds tracked by Wall St. Rank hold FMS as of Q4 2019.

  • Advisor Group held 2,126 shares of Fresenius Medical Care worth $78K as of Q4 2019.
  • Advisor Group sold 231 Fresenius Medical Care shares in Q4 2019, an estimated $8.19K.
  • Fresenius Medical Care made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3115 holding.
  • Advisor Group first reported a position in Fresenius Medical Care in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's Fresenius Medical Care position peaked at $449K in Q3 2017.
  • 171 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.